Skip to main content

Table 1 Distribution of yeast isolates per clinical samples

From: Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia

Clinical samples

Species

Vaginal swab

Oropharyngeal

Nail

Eye Discharge

Sputum

Total (n, %)

Candida albicans

52

30

4

5

13

104

Sub-total

     

104(49.8)

Non-albicans Candida

C. krusei

11

0

0

2

1

14(15.6)

C. famata

2

4

5

1

1

13(14.4)

C. rugosa

0

2

1

1

6

10(11.1)

C. lusitaniae

3

2

3

1

0

9(10)

C. dubliniensis

5

0

0

0

2

7(7.8)

C.lipolytica

2

4

0

0

0

6(6.7)

C. parapsilosis

2

4

0

0

0

6(6.7)

C. ciferrii

2

0

0

0

4

6(6.7)

C. kefyr

1

2

1

1

1

6(6.7)

C. guilliermondii

0

3

1

1

0

5(5.6)

C. pelliculosa

1

0

3

0

0

4(4.4)

C. glabrata

2

0

0

0

0

2(2.2)

C. intermedia

0

0

1

0

0

1(1.1)

C. utilis

0

1

0

0

0

1(1.1)

Sub total

 

.

   

90(43.1)

Other yeasts

Cryptoccocus laurenti

0

0

 

0

10

10(66.7)

C. neoformans

 

0

 

0

4

4(26.7)

Trichosporn mucoides

1

0

0

0

0

1(6.7)

Sub-total

     

15(7.2)

Grand Total (n, %)

84(40.2)

52(24.9)

19(9.1)

12(5.7)

42(20.1)

209